MedPath

The Comparison of Remimazolam and Dexmedetomidine on Bradycardia for Patients undergoing lower limb orthopedic surgery using Subarachnoid or Epidural nerve block

Not Applicable
Conditions
Diseases of the musculoskeletal system and connective tissue
Registration Number
KCT0007556
Lead Sponsor
Korea University Anam Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
44
Inclusion Criteria

1. Patients who have consented to the clinical trial and scheduled for orthopedic lower extremity surgery under regional anesthesia
2. Among patients between the ages of 19 and 80, ASA physical status classification system I-III

Exclusion Criteria

1. Patients who do not consent to clinical trials
2. Patients with spinal anesthesia level higher than T6
3. Patients currently taking beta blocker
4. Patients with a baseline heart rate of less than 50 bpm
5. Patient with previous spine surgery
6. Pregnant woman
7. Patients with body mass index (BMI) <18 or >30 kg/m2
8. Patients who are chronic alcoholics or who are taking psychiatric medications for a long time
9. Patients with a history of allergy to previous general anesthetics, patients with hypersensitivity to other benzodiazepines

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
frequency of bradycardia
Secondary Outcome Measures
NameTimeMethod
mean Blood pressure;mean heart rate;respiratory depression occurence; Rescue drug (phenylephrine, ephedrine, perdipine, midazolam) usage;Time to recover MOAA/S 4 points after completion of drug administration and time to recover aldrete score 9 points, which is the standard for leaving PACU after drug administration;occurrences of comorbidity (nausea, vomiting, mouth dryness, blurred vision, diziness, delirium)
© Copyright 2025. All Rights Reserved by MedPath